“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
The U.S. Food and Drug Administration (FDA) issued a draft guidance, titled Select Updates for the Breakthrough Devices Program Guidance: Reducing Disparities in Health and…
CITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for…
Overview Clinical trials are expensive and labor-intensive. Failures within the clinical trial process result in a huge loss of valuable resources and time. [1] These…
Season 1 – Episode 23: Open Access: Federal Rule Change As open access continues to become more prominent in the field of academic publishing, it…
Season 1 – Episode 22: Clery Act Training The Jeanne Clery Disclosure of Campus Security Policy and Campus Crime Statistics Act or Clery Act is…
“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
The U.S. Food and Drug Administration (FDA) issued a new final guidance, Multiple Endpoints in Clinical Trials Guidance for Industry. As the number of endpoints…
As part of their commitment to to supporting ethically conducted, high quality research, the National Institutes of Health (NIH) has released a new webpage, Animals…
The AAMC (Association of American Medical Colleges) and COGR (Council on Governmental Relations) have issued a response to NOT-AT-22-026, the NIH’s request for information, Investigators’…
“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
CITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for…
